Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06935877 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 24, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Interventions: Hyaluronic acid injection (Drug), Triamcinolone Acetonide (Drug) to Hyaluronic acid injection (Drug), Triamcinolone Acetonide injection (Drug)v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study employs a double-blind, randomized clinical trial design with 60 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: the experimental group receives combined hyaluronic acid and Triamcinolone Acetonide injections, while the control group receives hyaluronic acid alone injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.
Trial Details
NCT Number NCT06935877
Lead Sponsor Shin Kong Wu Ho-Su Memorial Hospital
Conditions
(from sponsor)		 Subdeltoid Bursitis of the Shoulder
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov